Wendy Cozen

Wendy Cozen, DO, MPH, is a Professor at the University of California, Irvine School of Medicine with joint appointments in multiple departments. She holds a professorship in the Division of Hematology and Oncology within the Department of Medicine, the Department of Epidemiology and Biostatistics in the School of Public Health, and the Department of Pathology. Her academic roles reflect a strong interdisciplinary focus spanning clinical medicine, population health, and molecular research.

Her research interests center on cancer epidemiology, particularly in hematologic malignancies, with a methodological emphasis on molecular and genetic epidemiology. These interests are deeply integrated across her appointments in medicine, public health, and pathology, indicating a translational research approach that bridges clinical observation with population-level data and laboratory-based analysis.

While no publications are currently accessible due to site maintenance, her affiliations suggest a research trajectory focused on the etiology and risk factors of cancers, particularly lymphoma and leukemia, using epidemiological and biostatistical methods. Her work likely involves large cohort studies, genetic susceptibility, and environmental exposures.

• Professor, Division of Hematology and Oncology, Department of Medicine
• Professor, Department of Epidemiology and Biostatistics
• Professor, Department of Pathology

Dr. Cozen plays a significant role in academic mentoring and research leadership across disciplines. Her triple appointment underscores her contributions to training the next generation of physician-scientists and epidemiologists, though specific advisees and grant funding details are not available in the current text. She is likely involved in multidisciplinary research teams and collaborative studies focused on cancer prevention and etiology.

She is affiliated with research centers and core facilities related to oncology, epidemiology, and pathology at UCI, though specific lab or team names are not mentioned. Her work may intersect with clinical trials and population health initiatives within the UCI Health system.